NATURAL HEALTH TRENDS CORP(NHTC)Stock Analysis
AI analysis on 2,800+ stocks →Deep AI analysis on 2,800+ stocks →13F Pro Quality Score
Rank #2,542 of 2,879 stocks
Rankings refresh quarterly once 80% of peers have filed (~45 days after quarter-end). Next update: ~Aug 14, 2026.
Revenue Growth
Profitability
Balance Sheet
Earnings Quality
Free Cash Flow
Institutional Flow
Revenue Scale
Dilution Risk
NHTC Stock Analysis & AI Quality Score
AI stock analysis and institutional research for NATURAL HEALTH TRENDS CORP (NHTC), a Consumer Staples sector company. 13F Pro's AI-powered ranking engine scores NHTC at 25.5/100 on a 32-signal composite quality model, placing it at rank #2,542 of 2,879 stocks — the bottom half of the AI-ranked universe. Areas of concern include revenue scale (9.1) and free cash flow (15.8), which score below median versus the broader universe. Based on the latest XBRL financial filings (Q1 2026), NATURAL HEALTH TRENDS CORP reports quarterly revenue of $9.2M, net income of $-154.0K, an operating margin of -5.1%. Top institutional holders of NHTC by reported 13-F value include RENAISSANCE TECHNOLOGIES, BlackRock,, GEODE CAPITAL MANAGEMENT,, based on the most recent SEC filings. NHTC trades on the Nasdaq exchange and files with the SEC under CIK 912061. 13F Pro's AI research platform runs 10 specialized AI analysts — value, growth, momentum, macro, and activist specialists — that debate NHTC daily and publish AI-generated analysis with cited SEC sources. The platform aggregates historical XBRL financial facts, 10-Q and 10-K filings, insider Form 4 transactions, and institutional 13-F holdings for NATURAL HEALTH TRENDS CORP directly from SEC EDGAR. NATURAL HEALTH TRENDS CORP's 13F Pro composite quality score has ranged between 21 and 31 since 2021, currently 25.5 — an improving long-term trajectory across 28 quarterly and live scoring snapshots.
Revenue
Q1 2026
$9.2M
Net Income
Q1 2026
$-154.0K
Free Cash Flow
Q1 2026
$-912.0K
Operating Margin
Q1 2026
-5.1%
ROIC
Q1 2026
-2.9%
Revenue & Net Income
Earnings Per Share
Key Financials Over Time
Export Financial Table · Pro+Revenue
-7.4% YoYNet Income
-254.2% YoYOperating Income
-39.2% YoYEPS (Diluted)
-260.0% YoYTotal Assets
-30.6% YoYOp. Cash Flow
-78.1% YoY| Metric | FY 2025 | FY 2024 | FY 2023 | FY 2022 | FY 2020 | FY 2019 |
|---|---|---|---|---|---|---|
| Revenue | $39.8M -7.4% | $43.0M -2.2% | $43.9M -10.6% | $49.1M -20.8% | $62.1M -20.0% | $77.6M |
| Net Income | $-882.0K -254.2% | $572.0K +0.7% | $568.0K +81.5% | $313.0K -62.9% | $843.0K +115.0% | $-5.6M |
| Operating Income | $-1.8M -39.2% | $-1.3M +22.3% | $-1.7M -518.9% | $-270.0K -140.4% | $669.0K +109.5% | $-7.0M |
| EPS (Diluted) | $-0.08 -260.0% | $0.05 +0.0% | $0.05 +66.7% | $0.03 -57.1% | $0.07 +113.5% | $-0.52 |
| Total Assets | $38.4M -30.6% | $55.4M -19.9% | $69.1M -16.6% | $82.8M -21.8% | $105.9M -10.6% | $118.5M |
| Operating Cash Flow | $-6.0M -78.1% | $-3.4M +21.3% | $-4.3M +11.8% | $-4.9M -357.4% | $1.9M +110.1% | $-18.6M |
AI Insight: NHTC Financial Trends
Revenue declined from $11M in Q4 2024 to $9M in Q1 2026 while equity contracted 57% from $37M to $16M over eight quarters.
• Revenue fell from $11M in Q4 2024 to $9M in Q1 2026, reflecting deteriorating business momentum.
• Equity contracted sharply from $37M in Q2 2024 to $16M in Q1 2026, a 57% decline.
• Operating cash flow remained persistently weak, turning negative $6M in Q2 2025 and $1M in Q1 2026.
⚠ Operating income turned negative $1M in Q4 2025 after hovering near breakeven for six quarters.
⚠ Equity erosion accelerated in Q1 2026 with $7M decline in single quarter, largest drop in dataset.
AI Insight: NHTC Ratio Trends
NHTC's profitability collapsed through 2025 with operating margins deteriorating from -2.3% to -6.5% and ROIC plunging to -11.5% by Q1 2026.
• Operating margin deteriorated from -2.3% in Q2 2024 to -6.5% in Q4 2025, showing accelerating operational decline.
• ROIC fell from -2.6% in Q2 2024 to -11.5% in Q1 2026, indicating severely impaired capital efficiency.
• Net profit margin turned deeply negative at -6.0% in Q4 2025 after hovering near breakeven earlier in 2024.
⚠ Sequential improvement in Q1 2026 with operating margin recovering to -5.1% from -6.5% may signal bottoming out.
⚠ Persistent negative ROIC across all quarters indicates fundamental business model challenges requiring strategic restructuring.
Get alerted when NHTC's score changes
Free account: watchlist tracking, the daily AI brief, and the AI screener.
Available Research
13F Pro tracks comprehensive data for NATURAL HEALTH TRENDS CORP including:
Top Institutional Holders of NHTC
RENAISSANCE TECHNOLOGIES LLC
$1.5M555,415 shBlackRock, Inc.
$324.0K116,134 shGEODE CAPITAL MANAGEMENT, LLC
$295.9K106,027 shVANGUARD CAPITAL MANAGEMENT LLC
$213.7K76,604 shVANGUARD FIDUCIARY TRUST CO
$97.4K34,905 shCITADEL ADVISORS LLC
$93.2K33,414 shDIMENSIONAL FUND ADVISORS LP
$76.2K27,297 shSTATE STREET CORP
$75.4K27,012 shBRIDGEWAY CAPITAL MANAGEMENT, LLC
$63.1K22,600 shUBS Group AG
$43.9K15,730 sh
| Fund | Value | Shares |
|---|---|---|
| RENAISSANCE TECHNOLOGIES LLC | $1.5M | 555,415 |
| BlackRock, Inc. | $324.0K | 116,134 |
| GEODE CAPITAL MANAGEMENT, LLC | $295.9K | 106,027 |
| VANGUARD CAPITAL MANAGEMENT LLC | $213.7K | 76,604 |
| VANGUARD FIDUCIARY TRUST CO | $97.4K | 34,905 |
| CITADEL ADVISORS LLC | $93.2K | 33,414 |
| DIMENSIONAL FUND ADVISORS LP | $76.2K | 27,297 |
| STATE STREET CORP | $75.4K | 27,012 |
| BRIDGEWAY CAPITAL MANAGEMENT, LLC | $63.1K | 22,600 |
| UBS Group AG | $43.9K | 15,730 |
More Consumer Staples Companies
View all Consumer Staples →Put NHTC on your watchlist
Track score changes the day NATURAL HEALTH TRENDS CORP files with the SEC, follow the hedge funds that own it, screen 2,800+ AI-scored stocks, and get the daily brief — free.
Free tier includes 13F data, economic indicators, and market overview. Pro starts at $6.67/mo (billed annually).
Popular Research
Is NHTC a good stock to buy?
13F Pro's AI-powered analysis of NATURAL HEALTH TRENDS CORP (NHTC) draws on SEC EDGAR-sourced fundamentals, institutional 13F holdings, and insider Form 4 transactions in the Consumer Staples sector (listed on Nasdaq). The 32-signal AI Quality Score, current rank, and full bull/bear verdict for NHTC are available on the NHTC stock profile dashboard — with the same data, AI insights, ratios, and institutional activity refreshed after every 10-K, 10-Q, 13F, and Form 4 filing.
Which hedge funds own NHTC?
Institutional investors are required to disclose their holdings quarterly via SEC Form 13F. 13F Pro aggregates these filings to show which hedge funds, mutual funds, and asset managers are buying or selling NHTC. Combined with insider transaction data from Form 4 filings and AI-powered analysis from 10 specialized research agents, 13F Pro provides a comprehensive view of NATURAL HEALTH TRENDS CORP's investment landscape.